Q418/FY18 Market Recap: US Surgical Matrices

The US Surgical Matrices Market continued to advance in Q418, driven by a resurgence of Becton Dickinson in hernia matrices and continued growth of breast matrices.  The US market grew +9.7% in FY18.

SmartTRAK reports that the US Surgical Matrices market grew in both the Breast and Hernia Repair segments. SmartTRAK estimates the Breast segment grew again at +21.8% YoY growth to 35.2% share of the entire Surgical Matrices market. The Hernia Repair market continued its recovery up +4.8% YoY and 64.8% share of the US Surgical Matrices Market in Q418.  

Among the many topics covered in the Q418/FY18 Surgical Matrices Market Recap are:

• Q418 Surgical Matrices Market Overview
• US Breast Matrices: ADM Growth Slows
• US Hernia Repair Matrices Market: BD Comes Back
• US Surgical Matrices Market Events

In Q418, Allergan continued to dominate the Breast Matrices segment with its AlloDerm ADM, and maintained its leadership of the Surgical Matrices market with a 32.6% share. Allergan experienced supply constraints with its AlloDerm, limiting growth modestly. BD recovered its synthetic hernia matrices business after Hurricane Maria to solidify its hold on the No. 2 market position and Ethicon grew only +0.3% YoY, capturing third place with 13.8% share. In fourth place, Medtronic grew...

Read the entire Q418/FY18 Surgical Matrices Market Recap including news, data and analysis*...